Hyperbaric Oxygen Therapy for Long COVID: What the Research Shows
At a Glance What it is: Pressurized-chamber oxygen therapy (1.5-2.0 ATA) applied over 40-60 sessions to address persistent Long COVID symptoms. Key evidence: A 2022 Israeli randomized controlled trial demonstrated significant cognitive and fatigue improvements in Long COVID patients after HBOT. Best for: Brain fog, chronic fatigue, exercise intolerance, and neurological symptoms that have persisted…









